#USA #Nashville #Kidney Care #Value-Based Care #Evergreen Nephrology

Evergreen Nephrology Secures $130 Million for Kidney Care Expansion

Evergreen Nephrology, a prominent entity in value-based kidney care, has successfully raised $130 million in funding, intended to augment its innovative care model for those suffering from kidney disease. This significant investment was spearheaded by Rubicon Founders, Oak HC/FT, and several pre-existing investors, along with new backing from K2 HealthVentures.

The raised capital will facilitate Evergreen's growth by enhancing their services in various regions while also integrating advanced technologies aimed at optimizing clinical results, simplifying care delivery processes, and alleviating the administrative workload faced by nephrologists.

Currently, over 37 million Americans are afflicted with chronic kidney disease, contributing to Medicare expenditures exceeding $95 billion annually. Evergreen's approach towards value-based care is crucial in addressing these pressing healthcare challenges.

John Donlan, the Chief Executive Officer of Evergreen Nephrology, emphasized the transformative impact of this funding: "This investment allows us to extend our care programs, which are fundamental in enhancing patient outcomes while concurrently reducing healthcare costs. Our mission is centered around instigating meaningful, positive changes for patients and families dealing with chronic kidney disease."

Moreover, Matt Kim, a Partner at Rubicon and co-founder of Evergreen Nephrology, highlighted the longstanding neglect of empowering nephrologists within the healthcare structure: "The healthcare system has consistently overlooked the urgent requirement to equip nephrologists with advanced kidney care management tools and resources. By providing them with the necessary support, Evergreen is addressing a significant void in the healthcare landscape, promoting a more effective and collaborative strategy for managing kidney illness."

Evergreen Nephrology prioritizes a collaborative strategy toward kidney treatment, working hand in hand with nephrologists to advance patient care outcomes. The organization affords nephrologists comprehensive support, integrating analytical insights and tools alongside a dedicated team that includes nurse care managers, care coordinators, social workers, dietitians, and pharmacists. This multidisciplinary approach ensures that patients benefit from personalized, holistic care, allowing nephrologists to focus on their expertise in managing kidney conditions.

With this funding, Evergreen is well-positioned to continue its mission of transforming kidney care throughout the United States, striving for improved access and outcomes for patients in need. Ropes & Gray LLP notably provided legal counsel to Evergreen in connection with this financial transaction.

About Evergreen Nephrology

Evergreen Nephrology collaborates with nephrologists and payers to reshape kidney care for those suffering from chronic and end-stage kidney diseases. With operations spanning 24 states and a network comprising over 900 healthcare providers, Evergreen delivers tailored, value-based care designed to empower patients while enhancing health outcomes. For more information, visit EvergreenNephrology.com.

Media Contact:
Corporate Communications
Evergreen Nephrology
Email: [Email Protected]

This milestone in fundraising underscores the critical imperative for advanced approaches to managing kidney health and the organization’s commitment to creating a sustainable impact within the realm of healthcare.